Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://www.spandidos-publications.com/ijo/34/2/529/abstract, but it redirected us to https://www.spandidos-publications.com/ijo/34/2/529/abstract. The analysis below is for the second page.

Title[redir]:
Capability of SART3109-118 peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles
Description:
We previously reported the SART3 gene to be a tumor-rejection antigen gene encoding a peptide at positions 109-118 (SART3109-118) with the ability to induce HLA-A24-restricted cytotoxic T lymphocytes. In this study, we investigated both humoral and cellular responses to this peptide in cancer patients with alleles other than HLA-A24 to explore the possibility of using this peptide as a cancer vaccine for these patients. IgG reactive to SART3109-118 peptide was identified in sera of the vast majority of non-cancer subjects (n=50) and all cancer patients (n=50) tested without apparent HLA-A association. Levels of anti-SART3109-118 peptide antibody in cancer patients were significantly higher than those of non-cancer subjects, but no difference was found between HLA-A24+A2− and HLA-A24−A2+ cancer patients. This peptide induced cancer cell-reactive cytotoxic T lymphocytes from peripheral blood mononuclear cells of both healthy donors and prostate cancer patients with HLA-A11, HLA-A31 and HLA-A33 alleles, but not with HLA-A2. These results suggest that this peptide can be applicable as a cancer vaccine not only for HLA-A24+, but also for HLA-A11+, HLA-A31+ and HLA-A33+ prostate cancer patients.

Matching Content Categories {📚}

  • Health & Fitness
  • Politics
  • News & Politics

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 75,579,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cancer, hlaa, journal, peptide, patients, oncology, information, international, spandidos, medicine, cited, sart, total, publications, citations, articles, citation, policy, molecular, reports, academy, issue, online, editorial, contact, cytotoxic, lymphocytes, prostate, alleles, article, cookie, home, read, crossref, authors, permissions, induce, view, february, metrics, pmc, statistics, ratio, abstract, gene, vaccine, noncancer, subjects, hlaaa, related,

Topics {✒️}

induce hla-a24-restricted cytotoxic hla-a24−a2+ cancer patients 1019-6439 online issn oncology molecular hla class i-a11 anti-sart3109-118 peptide antibody home submit manuscript field citation ratio clinical oncology experimental editor general information hla-a24+a2− prostate cancer patients a33 alleles authors hla-a33 alleles total pdf downloads related articles induce cytotoxic 9 ranked oncology spandidos publications permissions contact librarians information hla-a24 hla-a24+ hla-a2 igg reactive privacy policy cancer patients cookie policy hla-a11 hla-a11+ sart3 gene cancer vaccine cancer subjects apparent hla total views total number cookie settings hla-a31 hla-a31+ sart3109-118 peptide scope abstracting advertisers reprints conditions capability february 1 3892/ijo_00000178 pages pmc statistics previously reported cellular responses vast majority significantly higher

Social Networks {👍}(4)

External Links {🔗}(75)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager
  • Google Universal Analytics

Libraries {📚}

  • Fancybox
  • jQuery
  • jQuery module (jquery-3.4.1)
  • jQuery module (jquery-migrate-3.1.0)
  • jQuery module (jquery.fancybox)
  • jQuery module (jquery.jgrowl)
  • jQuery module (jquery.simplemodal)
  • Modernizr

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.7s.